Understanding the Hidden Layer of Cancer Biology
Cancer develops when genes malfunction. However, scientists now recognize that a cancer cell’s behavior also depends on how genetic instructions are edited before they produce proteins that keep cells alive.
A new study published in Nature Communications introduces an innovative method to directly measure this editing process, known as RNA Splicing. For the first time, researchers have gained a clearer view of how tumors systematically reorganize their genetic instructions to support growth and survival. This discovery may eventually open new avenues for controlling the disease.
Study Identifies New Therapeutic Targets
To test the approach, scientists analyzed solid tumor biopsies and identified around 120 potential therapeutic targets. These molecules could one day help researchers restore balance in the cellular editing machinery by either enhancing or suppressing their activity.
According to Dr. Miquel Anglada Girotto, the study’s first author and a postdoctoral researcher at the Center for Genomic Regulation in Barcelona, the research represents a new way to explore tumor biology. He explained that instead of simply counting cellular components, the team focused on understanding cellular behavior. As a result, the researchers gained a clearer roadmap for identifying new therapeutic strategies.
Measuring the Edits Instead of the Editors
Inside every cell, genetic instructions are first copied into temporary messages called RNA. Before these messages produce proteins, cells remove certain segments and stitch the remaining parts together. This editing process allows a single gene to create multiple protein variants, which is essential for complex biological functions.
However, cancers often manipulate this editing mechanism. Tumor cells alter how RNA messages are cut and assembled to produce protein variants that promote faster growth, evade immune responses, or resist treatment.
Traditionally, scientists have studied the molecules responsible for this editing, known as splicing factors. Yet these factors can be regulated in many hidden ways. For example, they may appear unchanged even while the proteins are destroyed, chemically modified, or relocated within the cell. Consequently, this approach often produces incomplete or confusing results.
A New Analytical Approach Using VIPER
To overcome this challenge, researchers from the Center for Genomic Regulation and Columbia University adopted a different strategy. Instead of examining the molecules performing the editing, they focused on the edits themselves.
As reported by medicalxpress, the team adapted an existing technology known as VIPER to analyze which segments of a gene’s message remain and which are removed. These patterns act like fingerprints on genetic messages, revealing which editing processes are truly active regardless of how the cellular editors are regulated.
Importantly, the method works with RNA Sequencing data, which researchers already collect extensively. As a result, scientists can apply the technique to thousands of existing datasets without conducting new experiments.
Two Hidden Cancer Editing Programs
Using this method, researchers examined nearly 10,000 tumor biopsies from 14 cancer types contained in The Cancer Genome Atlas. Each tumor sample was compared with corresponding healthy tissue.
The analysis revealed two major cellular editing programs that repeatedly appeared across different cancers. One program acted like an accelerator, becoming more active in tumors and correlating with poorer patient outcomes. In contrast, the second program behaved like a brake, weakening in cancer cells and linking to improved survival.
This finding suggests that despite their diversity, many cancers rely on common cellular editing strategies that previous gene-focused studies had overlooked.
Discovery of New Molecular Candidates
The researchers also investigated biological features that influence the balance of cellular editing toward cancer development. In doing so, they identified roughly one hundred candidate molecules.
Among the most notable was the gene FUS, which scientists have traditionally associated with neurological disorders. Although researchers have not widely studied it in cancer, its strong predictive signal in the study suggests it may play a significant role and warrants further investigation.
Broader Implications Beyond Cancer
The significance of this approach extends beyond oncology. Because the technique focuses on the outcomes of genetic editing rather than its specific causes, it may help scientists study a wide range of diseases in which cells alter how they assemble genetic instructions.
Dr. Anglada Girotto noted that the researchers initially focused on cancer because of the availability of extensive datasets. However, the method could also prove valuable for studying neurological conditions and immune-related disorders where cellular message editing plays a critical role.